Publications

5808 Results

Prostate specific antigen (PSA) as a predictor of adverse pathological features at prostatectomy in the Prostate Cancer Prevention Trial (PCPT)

Authors
MS Lucia;P Goodman;C Tangen;CA Coltman;IM Thompson
Journal / Conference
Journal of Urology 173(4):143 (#525)
Year
2005
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Short-and long-term genitourinary symptom status and global quality of life (QOL) from a Southwest Oncology Group (SWOG) trial

Authors
KA Hayden;CM Moinpour;J Faulkner;CM Tangen;ED Canby-Hagino;D Lemmon;S Breslin;IM Thompson;ED Crawford
Journal / Conference
Proc of the ASCO, JCO 23(16S):391s (#4556)
Year
2005
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8994 (EST-C-0690) (INT-0086)

Prognostic value of cell cycle regulators p27 and cyclin E: tissue microarray analysis of 1753 women enrolled in SWOG breast cancer trial 9313

Authors
PL Porter;W Barlow;IT Yeh;MG Lin;X Yuan;JN Ingle;CL Shapiro;GP Sledge;RB Livingston;DF Hayes
Journal / Conference
Proc of the ASCO, JCO 23(16S):5s (#507)
Year
2005
Research Committee(s)
Breast
Study Number(s)
SWOG-9313

Relationship between pretreatment CA-125 level and risk of relapse in advanced ovarian cancer (AOC) patients in a complete clinical response (CCR) who received "maintenance therapy"

Authors
PY Liu;DS Alberts;BJ Monk;M Brady;M Markman
Journal / Conference
Proc of the ASO, JCO 23(16S):458s (#5013)
Year
2005
Research Committee(s)
Gynecologic
Study Number(s)
S9701

Long term survival in stage IIIb non-small cell lung cancer (NSCLC) treated with consolidation docetaxel following concurrent chemoradiotherapy (SWOG S9504)

Authors
DR Gandara;K Chansky;LE Gaspar;KS Albain;PN Lara;J Crowley
Journal / Conference
Proc of the ASCO, JCO 23(16S):635s (#7059)
Year
2005
Research Committee(s)
Lung
Study Number(s)
SWOG-9504

Clinical benefit of Imatinib in patients (pts) with metastatic gastrointestinal stromal tumors (GIST) negative for the expression of CD117 in the S0033 trial.

Authors
ME Blackstein;C Rankin;C Fletcher;M Heinrich;R Benjamin;M von Mehren;C Blanke;JA Fletcher;E Borden;G Demetri
Journal / Conference
Proc of the ASCO, JCO 23(16S):818s (#9010)
Year
2005
Research Committee(s)
Sarcoma
Study Number(s)
S0033

Incidence and reasons for dose modification of standard-dose vs. high-dose imatinib mesylate (IM) in the phase III intergroup study S0033 of patients (pts) with unresectable or metastatic gastrointestinal stromal tumor (GIST)

Authors
P Dileo;CJ Rankin;RS Benjamin;M von Mehren;C Blanke;V Bramwell;R Maki;C Fletcher;EC Borden;GD Demetri
Journal / Conference
Proc of the ASCO, JCO 23(16S):824s (#9032)
Year
2005
Research Committee(s)
Sarcoma
Study Number(s)
S0033

SWOG S0102: a phase II study of docetaxel (DOC) and vinorelbine (VNR) + filgrastim for HER-2 negative, stage IV breast cancer

Authors
J Gralow;S Green;D Lew;W Barlow;KA Dammann;G Somlo;S Rivkin;S Taylor;L Wong;R Livingston
Journal / Conference
Proc of the ASCO, JCO 23(16S):20s (#567)
Year
2005
Research Committee(s)
Breast
Study Number(s)
S0102

Phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin's lymphoma (NHL): Southwest Oncology Group study S0108

Authors
AT Stopeck;W Bellamy;JM Unger;L Rimsza;M Iannone;RI Fisher;TP Miller
Journal / Conference
Proc of the ASCO, JCO 23(16S):583s (#6592)
Year
2005
Research Committee(s)
Lymphoma
Study Number(s)
S0108

Increased EGFR gene copy number detected by fish is associated with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma (BAC) (S0126)

Authors
FR Hirsch;DR Gandara;J McCoy;J Crowley;HJ West;PH Gumerlock;PA Bunn;WA Franklin;M Varella-Garcia
Journal / Conference
Proc of the ASCO, JCO 23(16S):628s (#7030)
Year
2005
Research Committee(s)
Lung
Study Number(s)
S0126